SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently garnering significant community attention as traders debate its role in institutional adoption, with many users actively discussing its potential for recovery amidst broader crypto market volatility. Community sentiment remains polarized, featuring a mix of long-term holders focused on staking and developers pushing various meme-based projects on the chain.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community debates its long-term utility versus short-term price action, with significant focus on an upcoming token unlock and high expectations for major partnerships in the pipeline. Investors are actively discussing the project's potential integration with institutional rails like XRP and Stellar, fueling a narrative of long-term holding despite current market volatility.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp (BATL) is trending as retail investors rally around its potential for a short squeeze amid escalating Middle East tensions and rising global oil prices. The community is heavily focused on the geopolitical impact on supply chains and energy infrastructure, with many debating the impact of insider activity versus bullish sentiment regarding energy sector independence.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon stock is currently trending due to a combination of escalating Middle East geopolitical risks impacting AWS cloud infrastructure in Bahrain and increased institutional interest driven by positive analyst target adjustments. While short-term traders are reacting to bearish flow divergence and regional conflict volatility, long-term investors are heavily debating the stock's valuation as a foundational AI play versus broader market concerns over consumer spending and potential recessionary headwinds.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors weigh strong 1Q26 booking momentum and expanding defense sector partnerships against disappointing quarterly revenue and wider-than-expected losses. The community is actively debating the stock's long-term valuation as a speculative "quantum pure-play" while navigating intense volatility driven by competitive pressures from other industry players and broader macroeconomic uncertainty.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets ($SSB) is currently trending as community members rally behind its recent launch, actively pushing for exchange listings and requesting updated charts to track momentum. Investors are highlighting the project's ambitious ecosystem plans and decentralized finance features, while discussions frequently emphasize the potential for long-term growth and the active involvement of the SatoshiStreetBets community.

Global X Funds - Global X Defense Tech ETF

Global X Defense Tech ETF

The Global X Defense Tech ETF is seeing significant momentum as investors capitalize on surging global military spending and persistent geopolitical tensions, with many in the community viewing it as a strategic long-term play for aerospace and autonomous technology. Traders are actively debating the integration of artificial intelligence and robotics into defense platforms, with many highlighting the ETF's diversified exposure to both domestic and international contractors as a key hedge against macroeconomic uncertainty.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna is trending due to surging interest in its European gas fields amid heightened geopolitical instability and supply concerns in the energy sector. Investors are closely monitoring the stock's tight float and high cost-to-borrow fees, with community discussions heavily focused on the potential for a short squeeze and the added leverage provided by the company's warrants.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors react to a significant analyst upgrade and anticipate the upcoming presentation of Phase 3 long-term clinical data at the American Academy of Dermatology conference. The community is actively discussing the stock's potential for acquisition, with ongoing debates centered on whether recent price volatility is driven by institutional accumulation or tactical suppression by market makers.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is surging following FDA approval of Vykat XR to treat hyperphagia in Prader-Willi syndrome patients, marking the first therapy of its kind for this rare disease. The community is actively discussing the stock's significant valuation shift, potential for commercial success, and ongoing speculation regarding its status as a high-conviction buyout candidate for larger pharmaceutical players.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Galapagos (NASDAQ:GLPG) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Galapagos from a "hold" rating to a "buy" rating in a research note on Saturday...

Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal

GILD expands into autoimmune therapies with an acquisition deal with Ouro Medicines, adding OM336 and advancing its push into next-gen immunology platforms.

Galapagos (NASDAQ:GLPG) Sees Large Volume Increase - Still a Buy?

Galapagos (NASDAQ:GLPG) Sees Large Volume Increase - Should You Buy...

Galapagos Q4 Earnings Call Highlights

Galapagos (NASDAQ:GLPG) executives used the company's year-end 2025 financial results call to outline a strategic reset centered on business development, following a decision to wind down its cell...

Galapagos (NASDAQ:GLPG) Shares Gap Up Following Earnings Beat

Galapagos (NASDAQ:GLPG) Shares Gap Up Following Better-Than-Expected Earnings...

<ul class="summary-bullets"><li>The winding down of the said activities will impact about 365 employees across regions including Europe, the U.S. and China, the company said.&nbsp;</li><li>It will also result in the shut down of sites in the Netherlands, Switzerland, U.S. and China.</li><li>Galapagos CFO Aaron Cox had said in November that the company expects to be cash flow neutral to positive by the end of 2026 if the wind down is implemented.</li></ul> Galapagos NV (GLPG) on Monday announced that its Board of Directors has decided to initiate the wind-down of the company’s cell therapy activities, sending shares up 6% in Monday’s after hours trading.The company had announced its intent to wind down the activities after a strategic review and sale process in October but had held on acting on it until it completed communicating with work councils in the Belgium and Netherlands. The winding down of the said activities will impact about 365 employees across regions including Europe, the U.S. and China, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/01/05/3213177/0/en/Galapagos-Announces-Board-Decision-to-Initiate-Wind-Down-of-Cell-Therapy-Activities.html">said</a>.It will also result in the shut down of sites in the Netherlands, Switzerland, the U.S. and China. The U.S. facilities to be shut down include one in Princeton and another in Pittsburgh, the company said. More details about the wind down, including details pertaining to its timeline and costs, will be provided with the company’s full year earnings in February, it added.Galapagos CFO Aaron Cox had said in November that the company expects to be cash flow neutral to positive by the end of 2026 if the wind down is implemented.<h2 class="st-heading-2">Future After Wind Down</h2>On Monday, Galapagos said that the wind-down of the cell therapy activities will position it for longer-term growth. The company will continue to manage its non-cell therapy programs and evaluate all strategic alternatives for GLPG3667, an investigational, oral, selective inhibitor of tyrosine kinase 2, to accelerate its development in dermatomyositis and potentially other severe auto-immune indications, the company said.The company will also consider resuming the partnering process for the drug, it said. Galapagos also added that it will continue to maintain its presence at its headquarters in Belgium as well as its hubs in Chicago and San Francisco.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, the retail sentiment about GLPG stayed in the ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<a href="https://stocktwits.com/symbol/GLPG">GLPG stock</a> has gained 15% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/toyota-us-sales-rise-8-percent-in-q4/cmxMCZPR4Ri">US Heeds Trump To Buy A Toyota: Japanese Automaker’s US Sales Rise 8% In Q4</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A logo of Galapagos, a European pharmaceutical research company, is pictured outside its facility on June 9, 2020 in Leiden, Netherlands. (Photo by Yuriko Nakao/Getty Images) 

Galapagos Stock Rises After Hours On Starting To Wind Down Cell Therapy Activities, Subsequent Workforce Reduction 

The company had announced its intent to wind down the activities after a strategic review and sale process in October.

Equity

The company had announced its intent to wind down the activities after a strategic review and sale process in October.


Galapagos NV (NASDAQ:GLPG) Given Consensus Rating of "Reduce" by Analysts

Galapagos NV (NASDAQ:GLPG - Get Free Report) has been given an average recommendation of "Reduce" by the nine research firms that are presently covering the company, MarketBeat reports. Five equities...

XTX Topco Ltd Makes New $1.11 Million Investment in Galapagos NV $GLPG

XTX Topco Ltd acquired a new stake in Galapagos NV (NASDAQ:GLPG - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired...

Segall Bryant & Hamill LLC Sells 150,384 Shares of Galapagos NV $GLPG

Segall Bryant & Hamill LLC cut its position in shares of Galapagos NV (NASDAQ:GLPG - Free Report) by 23.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the...

Galapagos (NASDAQ:GLPG) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised Galapagos from a "sell" rating to a "hold" rating in a research report on Sunday...

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Galapagos NV - ADR

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Current Price	$28.93
Prev Close	$29.97
Open	$29.98
Dividend Yield	0.00%
50-Day Moving Average	$33.26
Beta	0.54
Avg. Volume	100,899.99
PE Ratio	4.85

52-Week High	$37.78
52-Week Low	$22.59
Market Capitalization	$1.91B
EPS (Annual)	$5.50
Price to Book	0.50
Revenue Per Employee	$2.78M

GLPG
Galapagos

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GLPG News

GLPGGalapagos